Anticancer potentiality of lignan rich fraction of six Flaxseed cultivars

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorEzzat, Shahira M
dc.contributor.authorShouman S.A.
dc.contributor.authorElkhoely A.
dc.contributor.authorAttia Y.M.
dc.contributor.authorElsesy M.S.
dc.contributor.authorEl Senousy A.S.
dc.contributor.authorChoucry M.A.
dc.contributor.authorEl Gayed S.H.
dc.contributor.authorEl Sayed A.A.
dc.contributor.authorSattar E.A.
dc.contributor.authorEl Tanbouly N.
dc.contributor.otherPharmacognosy Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherCairo University
dc.contributor.otherKasr El-Einy Street
dc.contributor.otherCairo
dc.contributor.other11562
dc.contributor.otherEgypt; Department of Pharmacognosy
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherOctober University for Modern Science and Arts (MSA)
dc.contributor.other6th October
dc.contributor.other12566
dc.contributor.otherEgypt; Cancer Biology Department
dc.contributor.otherNational Cancer Institute
dc.contributor.otherCairo University
dc.contributor.otherCairo
dc.contributor.otherEgypt; Pharmacology and Toxicology Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherHelwan University
dc.contributor.otherHelwan
dc.contributor.otherEgypt
dc.date.accessioned2020-01-09T20:40:49Z
dc.date.available2020-01-09T20:40:49Z
dc.date.issued2018
dc.descriptionScopus
dc.descriptionMSA Google Scholar
dc.description.abstractThe objective of our study is to highlight the therapeutic effect and mechanism of action by which purified Flaxseed hydrolysate (PFH) which is a lignan rich fraction exerts its anticancer activity on a human breast cancer cell line (T47D) and in mice bearing tumor. HPLC analysis of PFH of six flaxseed cultivars had shown that PFH of the cultivar Giza 9 (PFH-G9) contains the highest concentration of SDG (81.64 mg/g). The in vitro cytotoxic potentiality of PFH's of six flaxseed cultivars was screened against a panel of human cancer cell lines. PFH -G9 showed the most significant cytotoxic activity against ER-receptor positive breast cell lines MCF7 and T47D with IC50 13.8 and 15.8 ?g/ml, respectively. Moreover, PFH-G9 reduced the expression of the metastasis marker, 1-?, metalloproteinases and vascular endothelial growth factor (VEGF), one of the most potent stimulators of angiogenesis, while it increased the caspase-3 dependent apoptosis. Our study also showed that dietary intake of 10% of Giza 9 Flaxseeds (FS), fixed oil (FSO) or Flax meal (FSM) twice daily for 3 weeks in mice-bearing solid Ehrlich ascites carcinoma (EAC) resulted in reducing the tumor volume, the expression of estrogen, insulin growth factor, progesterone, VEGF and MMP-2, but enhanced expression of caspase-3. � 2018 The Author(s).en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=21100200805&tip=sid&clean=0
dc.identifier.doihttps://doi.org/10.1038/s41598-017-18944-0
dc.identifier.doiPubMed ID 29323210
dc.identifier.issn20452322
dc.identifier.otherhttps://doi.org/10.1038/s41598-017-18944-0
dc.identifier.otherPubMed ID 29323210
dc.identifier.urihttps://t.ly/P5M8X
dc.language.isoEnglishen_US
dc.publisherNature Publishing Groupen_US
dc.relation.ispartofseriesScientific Reports
dc.relation.ispartofseries8
dc.subjectantineoplastic agenten_US
dc.subjectlignanen_US
dc.subjectplant extracten_US
dc.subjecttumor markeren_US
dc.subjectanimalen_US
dc.subjectapoptosisen_US
dc.subjectchemistryen_US
dc.subjectdrug effecten_US
dc.subjectexperimental mammary neoplasmen_US
dc.subjectfemaleen_US
dc.subjectflaxen_US
dc.subjectgeneticsen_US
dc.subjectHCT 116 cell lineen_US
dc.subjectHeLa cell lineen_US
dc.subjecthumanen_US
dc.subjectMCF-7 cell lineen_US
dc.subjectmetabolismen_US
dc.subjectmouseen_US
dc.subjectAnimalsen_US
dc.subjectAntineoplastic Agentsen_US
dc.subjectApoptosisen_US
dc.subjectBiomarkers, Tumoren_US
dc.subjectFemaleen_US
dc.subjectFlaxen_US
dc.subjectHCT116 Cellsen_US
dc.subjectHeLa Cellsen_US
dc.subjectHumansen_US
dc.subjectLignansen_US
dc.subjectMammary Neoplasms, Experimentalen_US
dc.subjectMCF-7 Cellsen_US
dc.subjectMiceen_US
dc.subjectPlant Extractsen_US
dc.titleAnticancer potentiality of lignan rich fraction of six Flaxseed cultivarsen_US
dc.typeArticleen_US
dcterms.isReferencedByMason, J.K., Thompson, L.U., Flaxseed and its lignan and oil components: Can they play a role in reducing the risk of and improving the treatment of breast cancer? (2014) Appl. Physiol. Nutr. Metab., 39, pp. 663-678; Mali, A.V., In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from flax lignan, and down-regulation of matrix metalloproteinases in MCF-7 and MDA MB 231 cell lines (2012) Indian J. Cancer., 49, pp. 181-187; Wiseman, H., The bioavailability of non-nutrient plant factors: Dietary flavonoids and phyto-oestrogens. Proceed (1999) Nut. Soc., 58, pp. 139-146; Tou, J.C., Thompson, L., Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures (1999) Carcinogenesis, 20, pp. 1831-1835; Knight, D.C., Eden, J.A., A review of the clinical effects of phytoestrogens (1996) Obstet. Gynecol., 87, pp. 897-904; Adlercreutz, H., Determination of urinary lignan and phytoestrogen metabolite, potential antiestrogens and anticarcinogens in urine of women on various habitual diets (1986) J. Steroid. Bioch., 25, pp. 791-797; Waldschl�ger, J., Flax-seed extracts with phytoestrogenic effects on a hormone receptor-positive tumor cell line (2005) Anticancer Res., 25, pp. 1817-1822; Yan, L., Yee, J.A., Li, D., McGuire, M.H., Thompson, L.U., Dietary flaxseed supplementation and experimental metastasis of melanoma cells in mice (1998) Cancer Lett., 124, pp. 181-186; Li, D., Yee, J.A., Thompson, L.U., Yan, L., Dietary supplementation with secoisolariciresinol diglycoside (SDG) reduces experimental metastasis of melanoma cells in mice (1999) Cancer Lett., 142, pp. 91-96; Lin, X., Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice (2002) Urology, 60, pp. 919-924; Chen, J., Stavro, P.M., Thompson, L.U., Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor (2002) Nutr. Cancer, 43, pp. 187-192; Thompson, L.U., Rickard, S.E., Orcheson, L.J., Seidl, M.M., Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis (1996) Carcinogensis, 17, pp. 1373-1376; Thompson, L.U., Seidl, M.M., Rickard, S.E., Orcheson, L.J., Fong, H.H., Antitumorigenic effect of a mammalian lignan precursor from flaxseed (1996) Nutr. Cancer, 26, pp. 159-165; Salim, E.I., Abou-Shafey, A.E., Masoud, A.A., Elgendy, S.A., Cancer chemopreventive potential of the Egyptian flaxseed oil in a rat colon carcinogenesis bioassay-implications for its mechanism of action (2011) Asian Pac. J. Cancer Prev., 12, pp. 2385-2392; Dwivedi, C., Natarajan, K., Matthees, D.P., Chemopreventive Effects of Dietary Flaxseed Oil on Colon Tumor Development (2005) Nutr. Cancer, 51, pp. 52-58; Williams, D.S., Chemopreventive effects of Flax seed oil and Flaxseed meal on azoxymethane-induced colon tumors inFisher 344 Male rats. Int (2008) J. Cancer Res., 4, pp. 28-40; Truan, J.S., Chen, J.M., Thompson, L.U., Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen (2010) Mol. Nutr. Food Res., 54, pp. 1414-1421; Boik, J., Natural Compounds in Cancer Therapy (2001) Oregon Medical Press, , Princeton, Minnesota, USA, p. 25; Deryugina, E.I., Quigley, J.P., Matrix metalloproteinases and tumor metastasis (2006) Cancer Metastasis Rev., 25, pp. 29-34; Attia, Y.M., EL-Abhar, H.S., Al Marzabani, M.M., Shouman, S.A., Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines (2015) BMC Cancer, 15, pp. 838-845; Nilsson, U.W., Garvin, S., Dabrosin, C., MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells (2007) Breast Cancer Res. Treat., 102, pp. 253-261; Fang, Y.J., Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colonic cancer cell line HT-29 (2008) Ai Zheng, 27, pp. 1172-1176; De Luca, A., Lamura, L., Gallo, M., Maffia, V., Normanno, N., Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration (2012) J. Cell Biochem., 113, pp. 3363-3370; Liang, Y., Brekken, R.A., Hyder, S.M., Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones (2006) Endocr. Relat. Cancer, 13, pp. 905-919; Bergman, J.M., Thompson, L.U., Dabrosin, C., Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo (2007) Clin. Cancer Res., 13, pp. 1061-1067; Mehlen, P., Puisieux, A., Metastasis: A question of life or death (2006) Nat. Rev. Cancer, 6, pp. 449-458; Maiuri, M.C., Zalckvar, E., Kimchi, A., Kroemer, G., Self-eating and self-killing: Crosstalk between autophagy and apoptosis (2007) Nat. Rev. Mol. Cell Biol., 8, pp. 741-752; Oren, M., Decision making byp53: Life, death and cancer (2003) Cell Death Differ, 10, pp. 431-442; Lee, J., Cho, K., Flaxseed sprouts induce apoptosis and inhibit growth in MCF-7 and MDA-MB-231 human breast cancer cells (2012) In Vitro Cell Dev. Biol. Anim., 48, pp. 244-250; Lim, L.Y., Vidnovic, N., Ellisen, L.W., Leong, C.O., Mutant p53 mediates survival of breast cancer cells (2009) British J. Cancer, 101, pp. 1606-1612; Inwald, E.C., Ki-67 is a prognostic parameter in breast cancer patients: Results of a large population-based cohort of a cancer registry (2013) Breast Cancer Res. Treat., 139, pp. 539-552; �berg, U.W., Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo (2011) PLoS One, 6, p. e25720; Azrad, M., Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer (2013) J. Med. Food, 16, pp. 357-360; Delman, D.M., Fabian, C.J., Kimler, B.F., Yeh, H., Petroff, B.K., Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development (2015) Nutr. Cancer, 67, pp. 857-864; Dupont, J., Le Roith, D., Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: New insights into their synergistic effects (2001) Mol. Pathol., 54, pp. 149-154; Saggar, J.K., Chen, J., Corey, P., Thompson, L.U., The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways (2010) Nutr. Cancer, 62, pp. 533-542; Chen, J., Saggar, J.K., Corey, P., Thompson, L.U., Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice (2009) J. Nutr., 139, pp. 2061-2066; Skehan, P., New colorimetric cytotoxicity assay for anticancer drug screening (1990) J. Natl. Cancer Inst., 82, pp. 1107-1112; Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-??CT (2001) Methods, 25, pp. 402-408; Casciola-Rosen, L., Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death (1996) J. Exp. Med., 183, pp. 1957-1964; Kim, K.J., Li, B., Houck, K., Winer, J., Ferrara, N., The vascular endothelial growth factor proteins: Identification of biologically relevant regions by neutralizing monoclonal antibodies (1992) Growth Factors, 7, pp. 53-64; Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) J. Anal. Biochem., 72, pp. 248-254; Osman, A.M., Sayed-Ahmed, M.M., Khayal, M.T., El-Merzabani, M.M., Hyperthermic potentiation of cisplatin on solid Ehrlich carcinoma (1993) Tumori, 79, pp. 268-272; Ellman, G.L., Tissue sulfhydryl groups (1959) Arch. Biochem. Biophys., 82, pp. 70-77; Draper, H.H., Hadley, M., Malondialdehyde determination as index of lipid peroxidation (1990) Methods Enzymol., 186, pp. 421-431
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Loading...
Thumbnail Image
Name:
s41598-017-18944-0.pdf
Size:
3.68 MB
Format:
Adobe Portable Document Format
Description: